Immuneering Corp
IMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001790340
No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Immuneering Corp as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −7 vs. Q4 2024
- Shares held
- 4.50M
- +196.1K (+4.6%) vs. Q4 2024
- Total value
- $6.84M
- −$2.49M (−26.7%) vs. Q4 2024
- New holders
- 5
- 9 more added
- Sold out
- 12
- 9 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $171.6M |
| Q1 2026 | 96 | $154.3M |
| Q4 2025 | 85 | $208.6M |
| Q3 2025 | 69 | $183.3M |
| Q2 2025 | 39 | $12.9M |
| Q1 2025 | 35 | $6.84M |
| Q4 2024 | 42 | $9.32M |
| Q3 2024 | 38 | $10.9M |
| Q2 2024 | 59 | $12.3M |
| Q1 2024 | 51 | $34.3M |
| Q4 2023 | 52 | $118.6M |
| Q3 2023 | 52 | $130.1M |
| Q2 2023 | 49 | $175.9M |
| Q1 2023 | 35 | $114.9M |
| Q4 2022 | 34 | $56.9M |
| Q3 2022 | 32 | $172.5M |
| Q2 2022 | 37 | $65.7M |
| Q1 2022 | 50 | $88.1M |
| Q4 2021 | 37 | $200.1M |
| Q3 2021 | 38 | $316.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Immuneering Corp; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 1 | $0 | 0.00% | +1 | New |
| SBI Securities Co., Ltd. | 74 | $112 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 228 | $347 | 0.00% | +228 | New |
| BNP Paribas Arbitrage, SA | 287 | $436 | 0.00% | −62−17.8% | Reduced |
| EverSource Wealth Advisors, LLC | 345 | $524 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 796 | $1.21K | 0.00% | −1,501−65.3% | Reduced |
| JPMorgan Chase & Co | 1,974 | $3.00K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 3,954 | $6.01K | 0.00% | +116+3.0% | Added |
| Tower Research Capital LLC (TRC) | 6,328 | $9.62K | 0.00% | +3,928+163.7% | Added |
| CIBC Private Wealth Group, LLC | 10,000 | $12.5K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 9,924 | $15.1K | 0.00% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 10,607 | $16.1K | 0.00% | +10,607 | New |
| Charles Schwab Investment Management Inc | 12,000 | $18.2K | 0.00% | +12,000 | New |
| Dimensional Fund Advisors LP | 13,366 | $20.4K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 20,000 | $30.4K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 20,869 | $31.7K | 0.00% | +20,869 | New |
| Millennium Management LLC | 23,065 | $35.1K | 0.00% | −79,871−77.6% | Reduced |
| UBS Group AG | 28,551 | $43.4K | 0.00% | −23,942−45.6% | Reduced |
| Bank of America Corp | 28,854 | $43.9K | 0.00% | −2,200−7.1% | Reduced |
| First Manhattan Co | 32,325 | $49.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 35,757 | $54.4K | 0.00% | −14,800−29.3% | Reduced |
| Northern Trust Corp | 39,729 | $60.4K | 0.00% | 00.0% | Unchanged |
| Tidemark, LLC | 44,400 | $67.5K | 0.02% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 60,449 | $91.9K | 0.00% | +9,100+17.7% | Added |
| TD Asset Management Inc | 71,066 | $108.0K | 0.00% | −79,810−52.9% | Reduced |
| State Street Corp | 78,535 | $119.4K | 0.00% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 82,667 | $125.7K | 0.00% | +290.0% | Added |
| HighTower Advisors, LLC | 83,960 | $127.6K | 0.00% | +12,600+17.7% | Added |
| Geode Capital Management, LLC | 225,817 | $343.3K | 0.00% | +17,430+8.4% | Added |
| Southport Management, L.L.C. | 245,000 | $372.4K | 1.61% | +30,000+14.0% | Added |
| BlackRock, Inc. | 316,530 | $481.1K | 0.00% | −2,233−0.7% | Reduced |
| Morgan Stanley | 467,226 | $710.2K | 0.00% | +13,126+2.9% | Added |
| Price T Rowe Associates Inc | 659,009 | $1.00M | 0.00% | −108,115−14.1% | Reduced |
| Marshall Wace, LLP | 807,969 | $1.23M | 0.00% | +786,537+3,669.9% | Added |
| Vanguard Group Inc | 1,056,922 | $1.61M | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −177,377−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −58,349−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −32,650−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −17,421−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −13,914−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −12,073−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −11,705−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Corsair Capital Management, L.P. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −659−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −63,740−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −16−100.0% | Sold out |